I look forward to contributing to the department’s ongoing efforts to shape the future of cancer care and to working with colleagues and students who are equally passionate about making a difference in the lives of patients.
James B. Yu, MD, MHS, FASTRODartmouth Cancer Center and the Geisel School of Medicine at Dartmouth have appointed James B. Yu, MD, MHS, FASTRO, to the department of radiation oncology and applied sciences, where he will serve as leader of the genitourinary radiation oncology program. He transitions to this new role from St. Francis Hospital in Connecticut. Prior to that, he served as professor and executive vice chair of the department of radiation oncology at Columbia University Irving Medical Center.
"I am honored to join the exceptional team in the department of radiation oncology at Dartmouth Cancer Center," said Yu. "I look forward to contributing to the department’s ongoing efforts to shape the future of cancer care and to working with colleagues and students who are equally passionate about making a difference in the lives of patients."
A graduate of the University of Michigan Medical School, Yu spent most of his postgraduate career at Yale, where he led the Smilow Cancer Hospital and Care Centers as associate chief medical officer for radiation oncology and professor of therapeutic radiology.
As a former Yale Center for Clinical Investigation scholar and member of the Cancer Outcomes, Public Policy and Effectiveness Research Center at Yale, Yu’s research centers on the comparative effectiveness of new radiation technologies and how these new technologies are adopted nationally. He has published over 390 original manuscripts and co-edited the textbooks Pocket Guide to Radiation Oncology and Principles of Clinical Cancer Research. He is the radiation oncology co-chair for the Southwest Oncology Group Genitourinary Cancers Committee, and a nationally-recognized expert in patient-reported outcomes.
Yu is currently the editor-in-chief of the Journal of the National Cancer Institute – Cancer Spectrum; deputy editor-in-chief of the journal Practical Radiation Oncology; is on the editorial boards of the Journal of Clinical Oncology - Clinical Cancer Informatics, JNCI, Journal of Surgical Oncology, and Oncology; and is a former editorial board member of the Journal of Clinical Oncology.
This appointment comes at an exciting time for the department of radiation oncology and applied sciences at the Dartmouth Cancer Center, as the institution continues to strategically expand its commitment to improving patient care through innovative therapies, cutting-edge research, and collaboration with leading institutions worldwide.
About Dartmouth Cancer Center
Since 1972, Dartmouth Cancer Center (DCC) has combined groundbreaking and advanced cancer research at Dartmouth and the Geisel School of Medicine with award-winning, personalized, compassionate, patient-centered cancer care and clinical trials. At its flagship location at Dartmouth Health’s Dartmouth Hitchcock Medical Center, with 14 locations across New Hampshire and Vermont, DCC is one of fewer than 60 National Cancer Institute-designated Comprehensive Cancer Centers nationally. Each year, DCC manages 74,000 appointments, treats more than 4,500 newly diagnosed patients, and currently offers more than 240 active clinical trials. DCC remains committed to excellence, outreach and education. DCC strives to create new knowledge and impact, accelerate integrated and collaborative research to prevent and cure cancer, enhance survivorship and promote cancer-related health equity. Learn more at cancer.dartmouth.edu.
About Dartmouth Health
Dartmouth Health, New Hampshire’s only academic health system and largest private employer, serves patients across New England. Dartmouth Health provides access to more than 2,300 providers in nearly every area of medicine, delivering care at its flagship hospital, Dartmouth Hitchcock Medical Center (DHMC) in Lebanon, NH. Its network of hospitals, outpatient centers, clinics and home care facilities, spans a broad geographical area. Year after year, DHMC is named the #1 hospital in New Hampshire by U.S. News & World Report, and is consistently recognized for high performance in numerous clinical specialties and procedures. Dartmouth Health includes Dartmouth Cancer Center, northern New England’s only National Cancer Institute-designated Comprehensive Cancer Centers and one of less than than 60 total nationally; Dartmouth Health Children’s, which includes the state’s only children’s hospital (Children’s Hospital at DHMC/CHaD) and more than 20 locations around the region; eight member hospitals in Lebanon, Keene, Claremont, Hampstead, and New London, NH, and Windsor and Bennington, VT; Dartmouth Health Home Care; Dartmouth Health Connected Care Center for Telehealth, serving patients as far away as Texas; and more than 30 primary and multi-specialty clinics across New Hampshire and Vermont. Through its partnership with Dartmouth College, Dartmouth’s Geisel School of Medicine and the White River Junction VA Medical Center, Dartmouth Health trains nearly 400 medical residents and fellows annually and performs cutting-edge research and clinical trials with international impact. Dartmouth Health and its more than 16,000 employees are committed to serving the healthcare needs of everyone in the communities it serves and to providing every patient with exceptional, state-of-the-art, personalized care. Learn more at dartmouth-health.org.